HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Are routine intensive care admissions needed after endovascular treatment of unruptured aneurysms?

AbstractSUMMARY:
Routine intensive care unit monitoring is common after elective embolization of unruptured intracranial aneurysms. In this series of 200 consecutive endovascular procedures for unruptured intracranial aneurysms, 65% of patients were triaged to routine (non-intensive care unit) floor care based on intraoperative findings, aneurysm morphology, and absence of major co-morbidities. Only 1 patient (0.5%) required subsequent transfer to the intensive care unit for management of a perioperative complication. The authors conclude that patients without major co-morbidities, intraoperative complications, or complex aneurysm morphology can be safely observed in a regular ward rather than being admitted to the intensive care unit.
AuthorsA M Burrows, A A Rabinstein, H J Cloft, D F Kallmes, G Lanzino
JournalAJNR. American journal of neuroradiology (AJNR Am J Neuroradiol) 2013 Nov-Dec Vol. 34 Issue 11 Pg. 2199-201 ISSN: 1936-959X [Electronic] United States
PMID23744695 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aneurysm, Ruptured (diagnosis, surgery)
  • Cerebral Revascularization (adverse effects, statistics & numerical data)
  • Critical Care (statistics & numerical data)
  • Diagnostic Tests, Routine (statistics & numerical data)
  • Health Services Misuse (statistics & numerical data)
  • Humans
  • Intensive Care Units
  • Intracranial Aneurysm (diagnosis, surgery)
  • Minnesota (epidemiology)
  • Patient Admission (statistics & numerical data)
  • Postoperative Complications (diagnosis, epidemiology, etiology)
  • Prognosis
  • Treatment Outcome
  • Utilization Review

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: